The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
CD56+ NK lymphomas:clinicopathological features and prognosis
Abstract
The surface molecule CD56 marks a category of malignant lymphoma of putative natural killer (NK) cell origin. We conducted a retrospective analysis of 24 cases of CD56+ NK lymphoma/leukaemia to define the clinicopathologic and prognostic features of this specific group of lymphomas. 56 cases of nasal lymphomas and 204 cases with an initial diagnosis of peripheral T‐cell lymphoma were retrospectively analysed. To specifically examine lymphomas of putative NK origin, only those that were negative for surface expression of CD3 but positive for CD56 were analysed. 24 cases were identified. The initial predominant sites of involvement were nasal (n =18), palate (n = 1), nodal (n = 1) and multi‐organ (n =4). Clinically, in patients with disease localized to one anatomical site (n = 20), most had symptoms confined to the nose, with a high percentage in early stage (I: 91%; IV: 9%). The marrow was not involved in any of these cases. However, patients with multi‐organ involvement at presentation (n = 4) behaved differently. All presented acutely with pancytopenia, hepatosplenomegaly, and marrow infiltration with haemophagocytosis. A leukaemic phase was observed in one case. Anthracycline containing combination chemotherapy resulted in complete remission in 75% of patients with localized disease, but only in 25% with multi‐organ involvement. The median survival of patients with localized disease was 12 months, compared with 2 months in the multi‐organ group (P =0.06); the disease‐free survival was significantly better in the former (P <0.01). The overall median survival of all patients was still poor at 11 months. We conclude that CD56+ NK lymphomas could be divided into two main patterns of disease presentations: localized (predominantly nasal), and multi‐organ involvement. Each has different clinicopathologic and prognostic features. Conventional chemotherapy appeared ineffective for the majority of patients, and innovative treatment modalities are needed to improve outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Development of human T and natural killer cells
Spits, H., Lanier, L., & Phillips, J. (1995) · Blood · doi:10.1182/blood.v85.10.2654.bloodjournal85102654 · Cited by 362
Reactive hemophagocytic syndrome—a clinicopathologic study of 40 patients in an oriental population
Wong, K.-F., & Chan, J. K. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90048-g · Cited by 183
Characterization of two patients with lymphomas of large granular lymphocytes
Pandolfi, F., Pezzutto, A., Rossi, G., Pasqualetti, D., Semenzato, G., Quinti, I., Ranucci, A., Raimondi, R., Basso, G., Strong, D. M., et al. (1984) · Cancer · Cited by 37
Cited by
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Au, W.-Y., Weisenburger, D. D., Intragumtornchai, T., Nakamura, S., Kim, W.-S., Sng, I., Vose, J., Armitage, J. O., Liang, R., & for the International Peripheral T-Cell Lymphoma Project (2009) · Blood · doi:10.1182/blood-2008-10-185256 · Cited by 736
Self-citation
Metadata
- Authors
- KWONG, Y. L., CHAN, LIANG, R., CHIANG, A. K. S., CHIM, C. S., CHAN, T. K., TODD, D., & HO, F. C. S.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1997-06
- Volume
- 97
- Issue
- 4
- Pages
- 821-829
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1985239180
- Cited by
- 268
- References
- 5
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD56+ NK lymphomas:clinicopathological features and prognosis. https://app.cochat.ai/papers/10.1046/j.1365-2141.1997.1462962.x
- The paper
- KWONG, Y. L., CHAN, LIANG, R., CHIANG, A. K. S., CHIM, C. S., CHAN, T. K., TODD, D., & HO, F. C. S. (1997). CD56+ NK lymphomas:clinicopathological features and prognosis. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1997.1462962.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.